RESVERATROL SUPPLEMENTATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A PROSPECTIVE, OPEN LABEL, RANDOMIZED CONTROLLED TRIAL  

Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2013, Vol 4, Issue 8

Abstract

Resveratrol has been reported for its wide ranging beneficial effects on the biological system. The objective of the present study was to evaluate the effect of oral supplementation of resveratrol in patients with type 2 diabetes mellitus. A prospective, open label, randomized controlled trial was, therefore, conducted at Government Headquarters Hospital, Ootacamund, India, in which sixty two patients with T2DM were enrolled. Patients were randomized into control and intervention groups. The control group received only oral hypoglycemic agents whereas the intervention group received resveratrol (250 mg / day) along with oral hypoglycemic agents for a period of six months. HbA1C, lipid profile, oxidative stress, urea nitrogen, creatinine and protein were measured at the base line and at the end of six months. Of the 62 recruited subjects, 57 completed the study, namely 29 patients in the control group and 28 patients in the intervention group. The results reveal that supplementation of resveratrol for six months significantly decreases body weight, systolic blood pressure, total cholesterol, triglyceride, urea nitrogen and total protein. Significant increase in the level of antioxidant enzymes, namely superoxide dismutase, catalase, reduced glutathione was also observed, in addition to significant decrease in the lipid peroxidation. Resveratrol also decreases the levels of HbA1c and fasting blood glucose. However, these changes were not statistically significant. Resveratrol supplementation in patients with T2DM is found to be effective in improving associated vascular risk factors and glycemic control. Resveratrol could, therefore, be used as an effective adjuvant therapy with a conventional hypoglycemic regimen for the management of diabetes. 

Authors and Affiliations

Jayesh Bhatt , Moola Nanjan

Keywords

Related Articles

ANALGESIC AND CYTOTOXIC ACTIVITIES OF THREE REPUTED BANGLADESHI MEDICINAL PLANTS 

Plants have been one of the important sources of medicines since the beginning of human civilization. There is a growing demand in the present world for plant based medicines, health products, pharmaceuticals, food suppl...

EVALUATION OF ANTIMICROBIAL ACTIVITY AND PRELIMINARY PHYTO-CHEMICAL STUDIES ON WHOLE PLANT OF STACHYTARPHETA JAMAICENSIS (L.)VAHL  

The antimicrobial activity and preliminary phyto-chemical studies on whole plant of Stachytarpheta jamaicensis were evaluated. The shade dried and coarsely powdered plant was successively extracted with n-hexane, chloro...

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF CURCUMIN IN TABLET DOSAGE FORM BY RP-HPLC METHOD 

A rapid, sensitive and specific RP-HPLC method involving UV detection was developed and validated for determination and quantification of curcumin in tablet dosage form. Chromatography was carried out on a pre-packed Li...

CORRELATION BETWEEN PHYTOCHEMICAL SCREENING, ANTIBACTERIAL AND ANTHELMINTIC ACTIVITIES OF ELAEOCARPUS SERRATUS 

The petroleum ether, benzene, chloroform and acetone extracts of Elaeocarpus serratus were prepared by following Soxhlet method of extraction. Subsequently, phytochemical screening of the extracts was performed by follow...

PHARMACOGNOSY AND PHYTOCHEMICAL EVALUATION OF ROOTS OF ECHINOPS ECHINATUS ROXB.  

The genus Echinops echinatus Roxb. belongs to family Asteraceae found in India. Commonly known Kantaphala as in Sanskrit Roots used as medicine. It is used in dyspepsia, scrofula, syphilis and fever. It is also advised t...

Download PDF file
  • EP ID EP141274
  • DOI 10.7897/2230-8407.04849
  • Views 71
  • Downloads 0

How To Cite

Jayesh Bhatt, Moola Nanjan (2013). RESVERATROL SUPPLEMENTATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A PROSPECTIVE, OPEN LABEL, RANDOMIZED CONTROLLED TRIAL  . International Research Journal of Pharmacy (IRJP), 4(8), 245-249. https://europub.co.uk/articles/-A-141274